Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7216)
All Articles published online
|
Publishing Process of This Article
|
Jun 5, 2025 (publication date) through Mar 5, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Fennessy A, Doyle M, Boland A, Bourke R, O'Connor A. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial). World J Gastrointest Pharmacol Ther 2025; 16(2): 101268 [PMID: 40575360 DOI: 10.4292/wjgpt.v16.i2.101268] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Fennessy A, Doyle M, Boland A, Bourke R, O'Connor A. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial). World J Gastrointest Pharmacol Ther 2025; 16(2): 101268 [PMID: 40575360 DOI: 10.4292/wjgpt.v16.i2.101268] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v16/i2/101268.htm |
| Number | Citing Articles |
| 1 |
Yixuan Li. Gut microbiota in the pathogenesis and treatment of inflammatory bowel disease: a critical review of mechanisms and therapeutic advances. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1738292
|
| 2 |
Xuemei Li, Qiang Yuan, Hui Huang, Li Wang. Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1695321
|